An Open-label, Randomized, 2x2 Crossover Study to Compare the Pharmacokinetics and Safety Following Administration of DWJ1451 and Co-administration of DWC202008 and DWC202009 in Healthy Volunteers
Latest Information Update: 05 Jan 2023
At a glance
- Drugs Amlodipine/olmesartan/ezetimibe/rosuvastatin (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Daewoong Pharmaceutical
- 31 Mar 2021 New trial record